| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | World | 31,179.32 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | United States | 28,968.63 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Saudi Arabia | 927.18 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Israel | 286.35 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Chile | 255.55 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Other Asia, nes | 241.60 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Bermuda | 141.45 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | France | 90.73 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Australia | 80.66 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Kuwait | 62.10 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Jordan | 57.14 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Singapore | 18.46 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Peru | 15.53 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Japan | 9.48 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Ecuador | 7.34 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | New Zealand | 6.58 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Sweden | 4.32 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | China | 2.04 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | United Kingdom | 1.88 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Guyana | 0.65 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Korea, Rep. | 0.55 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Italy | 0.53 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Germany | 0.31 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Vietnam | 0.22 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Poland | 0.03 | | |
| Canada | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | United States Minor Outlying I | 0.02 | | |
